Article

Patients With Cancer Facing Higher Rates of Loneliness, Depression During COVID-19 Pandemic

Loneliness and social isolation have been particularly significant problems for patients with cancer during the COVID-19 pandemic, likely due to isolation and social distancing, according to a study published in Cancer. According to its authors, this is the first study to evaluate loneliness, anxiety, depression, fatigue, and other symptoms in a single group of patients.

“We found that oncology patients were experiencing a deep sense of loneliness," said Christine Miaskowski, RN, PhD, a professor in the UCSF School of Nursing, in a prepared statement. “For these patients, the burden of their symptoms is extremely high, and oncology clinicians can suggest a number of strategies to help them. Patients should be encouraged to maintain contact with family and friends, and structure their daily routines when possible—through outdoor activities for example—as well as to maintain a healthy diet and sufficient sleep. These suggestions might mitigate some of the negative effects of loneliness.”

The study was conducted using a survey of 606 oncology patients conducted in May 2020, evaluating the severity of loneliness, social isolation, and related symptoms such as anxiety, depression, fatigue, sleep disturbance, cognitive dysfunction, and pain.

Overall, 53% of participants were categorized as having a high degree of loneliness, significantly higher than pre-pandemic levels (estimated to be between 32% and 47%). Approximately one-third had moderately high degrees of loneliness, and 5.3% reported high levels of depression.

The high-loneliness group was significantly more likely to be younger than the non-lonely group, and less likely to be married or partnered. They also had a higher number of comorbidities, and were more likely to report a diagnosis of depression and back pain. Lower levels of household income were associated with higher levels of loneliness, which the authors suggest could be due to individuals with higher incomes having more opportunities to engage in social activities and reciprocate in social relationships.

Nearly 83% of the patients in the lonely group had been diagnosed with breast cancer. One-third were currently in cancer treatment, and one-quarter had metastatic disease. Nearly 92% of the participants were female, which meant the authors could not draw conclusions based on sex differences.

The majority of participants were White, well-educated, and had an annual income of $60,000 or more. As such, the authors said, their findings may not be representative of all patients with cancer, and symptoms could be higher in patients who are socioeconomically disadvantaged.

REFERENCE

Cancer patients lonely and depressed during COVID [news release]. EurekAlert; May 6, 2021. Accessed May 10, 2021. https://www.eurekalert.org/pub_releases/2021-05/uoc--cpl050621.php

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com